Publication | Closed Access

Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis

HepatologyHepatocellular Carcinoma PatientsHepatocellular CarcinomaMedicinePharmacologyPd1 InhibitorsPharmacotherapyLiver CancerCancer TreatmentLiverOncologyRadiation OncologyTumor MicroenvironmentInduction Therapy